Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma.
Kawai T, Kurokawa Y, Taguchi S, Honda K, Maki K, Ambe Y, Saegusa N, Yamamoto M, Miyakawa J, Tokura Y, Inoue H, Tanaka T, Nara K, Kaneko T, Fujii Y, Kamei J, Kakutani S, Yamada Y, Niimi A, Yamada D, Takada T, Nakagawa T, Kume H.
Kawai T, et al. Among authors: yamamoto m.
Jpn J Clin Oncol. 2025 Jan 15:hyaf001. doi: 10.1093/jjco/hyaf001. Online ahead of print.
Jpn J Clin Oncol. 2025.
PMID: 39812300